Intermittent fasting's diabetes benefits vanish when the fasting stops

Intermittent fasting has become one of the most popular eating patterns for managing blood sugar and weight, and people with type 2 diabetes are often drawn to it. The open question has never really been whether fasting can move the numbers, but whether it moves them any better than other structured diets, and whether the improvements survive over time. This review set out to answer both, comparing fasting against continuous energy restriction, standard diets, the Mediterranean diet and eating freely, over short and longer horizons. For a condition managed across decades, durability matters at least as much as the initial drop.

The authors searched MEDLINE, EMBASE and the Cochrane Library up to August 20, 2023 for randomised trials of intermittent fasting in people with type 2 diabetes, excluding studies without a control group or with other interventions. Twelve articles covering 966 participants made the cut. Outcomes were split into short term, meaning under three months, and long term, meaning three months or more, and results for glycated haemoglobin, fasting plasma glucose and body weight were pooled using a random effects model. Risk of bias was assessed with a standard Cochrane tool.

In the short term, intermittent fasting beat the control diets on all three headline measures: glycated haemoglobin fell, fasting glucose fell and body weight dropped, all by statistically meaningful margins. Over the long term, however, fasting performed no better than the comparison diets; the effects were similar. Crucially, the metabolic benefits did not endure after people stopped fasting. The authors also flag substantial disagreement between the included studies, which means the size of the short-term effects should be read as approximate rather than precise.

This lands in the middle of a familiar pattern in diet research: most structured eating approaches produce early wins that converge with other diets over time. The review supports the authors' starting position that fasting is at least as good as other dietary controls for people with type 2 diabetes, while undercutting the idea that it does anything uniquely lasting to metabolism. What it cannot settle is which fasting schedule works best, how adherence shaped the long-term results, or whether people who sustain fasting for years fare differently. The heavy disagreement between studies leaves those questions open.

If you have type 2 diabetes or are watching your blood sugar, this is a reason to think of intermittent fasting as a tool that works while in use rather than a treatment that resets anything permanently. The short-term improvements in blood sugar and weight look real in these pooled trials, and the authors describe longer-term fasting as safe and feasible for managing blood sugar and weight while it continues. Equally, there is no sign here that fasting outperforms other sensible diets once past the first few months, so the best eating pattern may simply be the one that can be kept up.